Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | Newcastle University |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
22 December 2022
Closed
Estimated Value
£350,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £350,000 |
| Release Date: | 2 March 2023 |
| Application Deadline: | 22 December 2022 |
| Contract Start Date: | 2 February 2023 |
| Contract End Date: | 3 February 2027 |
| Contract Duration: | 4.1 years |
| Procurement ID (OCID): | ocds-b5fd17-9be37098-b387-4e25-a3ac-cf1a5c582e9e |
| Notice Reference: | b9eb6f59-e76b-4617-befe-cf6da4ed8c3d-620384 |
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £385,641 |
| Award decision date: | 1 February 2023 |
| Award status: | Active |
Within Newcastle University the Genomics Core Facility (GCF) is a state-of-the-art Next-Generation Sequencing laboratory that specialises in single-cell and spatial transcriptomics applications and supports a wide range of sequencing-based research within the Faculty of Medical Sciences (FMS) and beyond. The sequencing technology currently available within the facility is based on a clonally amplified short-read approach. As part of an MRC equipment award the University are seeking to purchase a high-throughput, scalable, long-read single-molecule sequencer. The scope of the contract is for the supply of the equipment and proprietary consumables, delivery, installation, training, 4 years of maintenance and servicing cover to begin once the 12-month warranty period has expired and proprietary consumables for 5 years post installation (to be purchased as and when required). The sequencer will be operated by dedicated and experienced NGS staff and will play a central role in large-scale discovery and translational research programmes involving genomic, transcriptomic, epigenomic and single cell analysis.